Wilmer Eye Institute, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eye (Lond). 2023 Apr;37(6):1123-1129. doi: 10.1038/s41433-022-02080-9. Epub 2022 Apr 29.
BACKGROUND/OBJECTIVE: To characterize incidence rates and identify risk factors for admission and mortality in patients with endogenous endophthalmitis (EE) in the United States (US).
SUBJECTS/METHODS: Patients with EE were identified using the Nationwide Emergency Department (NEDS) Database from 2006 to 2017 in this cross-sectional study. Subjects were required to have diagnoses of both endophthalmitis and septicaemia using contemporary International Classification of Diseases diagnosis codes. Incidence rates, mortality rates and demographics were evaluated. Risk factors for admission and mortality were identified using weighted logistic regression analysis.
A total of 6400 patients with EE were identified. Incidence increased from 0.10 (95% confidence interval [CI]: 0.07-0.12) per 100,000 in the US population in 2006 to 0.25 (95% CI: 0.21-0.30) in 2017 (p < 0.05). Most were female (55.4%), insured with Medicare (53.5%), were in the first income quartile earnings (29.3%) [bottom 25% income bracket], lived in the South (40.5%), and presented to metropolitan teaching hospitals (66.6%). Mortality increased from 8.6% (95% CI: 3.8-18.3%) in 2006 to 13.8% (95% CI: 9.7-19.2%) in 2017 (p = 0.94). Factors predicting admission included older age (odds ratio [OR] 32.59; [95% CI 2.95-359.78]) and intravenous drug use (OR 14.90 [95% CI: 1.67-133.16]). Factors associated with increased mortality included: human immunodeficiency virus infection/immune deficiencies (OR 2.58 [95% CI: 1.26-5.28]), heart failure (OR 2.12 [95% CI: 1.47-3.05]), and hepatic infections/cirrhosis (OR 1.89 [95% CI: 1.28-2.79]). Pneumonia and renal/urinary tract infections (UTI) were associated with both increased hospital admission [(pneumonia OR 9.64 (95% CI: 1.25-74.35, p = 0.030), renal/UTI OR 4.09 (95% CI: 1.77-9.48)] and mortality [(pneumonia OR 1.64 (95% CI: 1.17-2.29, p = 0.030), renal/UTI OR 1.87 (95% CI: 1.18-2.97)]. Patients with diabetes mellitus (DM) had decreased odds ratio for mortality (OR 0.49 [95% CI: 0.33-0.73]).
EE has increased in incidence throughout US. The two systemic factors that conferred both an increase in mortality and admission were pneumonia, and renal/UTI. Additional exploration of the potential protective association of DM with decreased mortality in this context is needed.
背景/目的:在美国(US),描述内源性眼内炎(EE)患者的住院和死亡发生率,并确定其风险因素。
本横断面研究使用 2006 年至 2017 年全国急诊数据库(NEDS)数据库来确定 EE 患者。要求患者使用当代国际疾病分类诊断代码同时诊断眼内炎和败血症。评估了发病率、死亡率和人口统计学数据。使用加权逻辑回归分析确定了住院和死亡的风险因素。
共确定了 6400 名 EE 患者。发病率从 2006 年每 10 万人口的 0.10(95%置信区间[CI]:0.07-0.12)增加到 2017 年的 0.25(95% CI:0.21-0.30)(p<0.05)。大多数患者为女性(55.4%),医疗保险(Medicare)保险(53.5%),收入处于第一收入四分位数(29.3%)[收入最低的 25%)],居住在南部(40.5%),并就诊于大都市教学医院(66.6%)。死亡率从 2006 年的 8.6%(95% CI:3.8-18.3%)增加到 2017 年的 13.8%(95% CI:9.7-19.2%)(p=0.94)。预测住院的因素包括年龄较大(优势比[OR] 32.59;[95% CI 2.95-359.78])和静脉药物使用(OR 14.90 [95% CI: 1.67-133.16])。与死亡率增加相关的因素包括:人类免疫缺陷病毒感染/免疫缺陷(OR 2.58 [95% CI: 1.26-5.28])、心力衰竭(OR 2.12 [95% CI: 1.47-3.05])和肝感染/肝硬化(OR 1.89 [95% CI: 1.28-2.79])。肺炎和肾脏/尿路感染(UTI)与住院(肺炎 OR 9.64 [95% CI: 1.25-74.35,p=0.030],肾脏/UTI OR 4.09 [95% CI: 1.77-9.48)]和死亡率(肺炎 OR 1.64 [95% CI: 1.17-2.29,p=0.030],肾脏/UTI OR 1.87 [95% CI: 1.18-2.97)]都相关。糖尿病(DM)患者的死亡率降低(OR 0.49 [95% CI: 0.33-0.73])。
EE 在全美范围内的发病率有所增加。导致死亡率和住院率增加的两个全身因素是肺炎和肾脏/UTI。需要进一步探索 DM 与降低这种情况下死亡率的潜在保护作用。